Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Donald Trump threatens “major tariff” on pharmaceuticals.

Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society.

Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”

We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US.

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.